Literature DB >> 7616363

Evidence for a common intermediate in insulin deamidation and covalent dimer formation: effects of pH and aniline trapping in dilute acidic solutions.

R T Darrington1, B D Anderson.   

Abstract

The effects of pH and aniline trapping on the partitioning of the A-21 cyclic anhydride intermediate of human insulin into deamidated insulin and covalent dimer were investigated at low pH and 35 degrees C. Characterization of the covalent dimer was achieved by proteolytic cleavage and electrospray mass spectrometry and indicated that the deamidated A-21 asparagine of one insulin molecule and the B-1 phenylalanine residue of another are involved. Anhydride trapping with aniline at pH 4.0 provided evidence that the rate-limiting generation of a cyclic anhydride intermediate is involved in the formation of both deamidated and dimeric insulin. In the presence of aniline at pH 4.0 insulin formed two anilide products, A-21 N delta 2-phenylasparagine and N delta 2-phenylasparagine and N gamma 2-phenylaspartic acid human insulin at the expense of both desamido A-21 and covalent dimer formation, consistent with the formation of a common intermediate. At 35 degrees C and under conditions where the insulin monomer predominates, the fraction of insulin reacting to form [desamidoA-21] insulin decreased with a concurrent increase in formation of [desamidoA-21-PheB-1] dimer with an increase in pH from 2.0 to 5.0. The pH dependence of insulin product distribution could not be quantitatively rationalized solely in terms of the fraction of the PheB-1 amine group in un-ionized form. Rather, consideration of the charge states of ionizable residues near the reacting groups was necessary to fully account for the observed pH effects on product formation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616363     DOI: 10.1002/jps.2600840303

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  15 in total

1.  Protein identification by in-gel digestion, high-performance liquid chromatography, and mass spectrometry: peptide analysis by complementary ionization techniques.

Authors:  K F Medzihradszky; H Leffler; M A Baldwin; A L Burlingame
Journal:  J Am Soc Mass Spectrom       Date:  2001-02       Impact factor: 3.109

2.  Kinetics and mechanisms of deamidation and covalent amide-linked adduct formation in amorphous lyophiles of a model asparagine-containing Peptide.

Authors:  Michael P Dehart; Bradley D Anderson
Journal:  Pharm Res       Date:  2011-10-18       Impact factor: 4.200

3.  The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form.

Authors:  M J Pikal; D R Rigsbee
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

4.  Structure and composition of insulin fibril surfaces probed by TERS.

Authors:  Dmitry Kurouski; Tanja Deckert-Gaudig; Volker Deckert; Igor K Lednev
Journal:  J Am Chem Soc       Date:  2012-08-03       Impact factor: 15.419

5.  Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin.

Authors:  Christian Fogt Hjorth; František Hubálek; Jonatan Andersson; Christian Poulsen; Daniel Otzen; Helle Naver
Journal:  Pharm Res       Date:  2015-01-14       Impact factor: 4.200

6.  Surface characterization of insulin protofilaments and fibril polymorphs using tip-enhanced Raman spectroscopy (TERS).

Authors:  Dmitry Kurouski; Tanja Deckert-Gaudig; Volker Deckert; Igor K Lednev
Journal:  Biophys J       Date:  2014-01-07       Impact factor: 4.033

7.  Solid-state stability of human insulin. I. Mechanism and the effect of water on the kinetics of degradation in lyophiles from pH 2-5 solutions.

Authors:  R G Strickley; B D Anderson
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

8.  Kinetics and mechanism for the reaction of cysteine with hydrogen peroxide in amorphous polyvinylpyrrolidone lyophiles.

Authors:  Dayong Luo; Bradley D Anderson
Journal:  Pharm Res       Date:  2006-09-02       Impact factor: 4.200

9.  Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues.

Authors:  Ugo Bilati; Eric Allémann; Eric Doelker
Journal:  AAPS PharmSciTech       Date:  2005-12-01       Impact factor: 3.246

10.  Effect of ethylenediamine on chemical degradation of insulin aspart in pharmaceutical solutions.

Authors:  Christian Poulsen; Dorte Jacobsen; Lisbeth Palm
Journal:  Pharm Res       Date:  2008-07-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.